Tag: diabetic foot
“Unacceptably high” major amputation rates and the effects of COVID on...
William Jeffcoate (Nottingham, UK) discusses his upcoming presentation at the Hurting Leg session at CX 2021, titled The impact of socio-economic and clinical variables...
VisionQuest Biomedical and The University of New Mexico combine artificial intelligence...
VisionQuest Biomedical and the University of New Mexico School of Medicine have been awarded a three-year US$3 million grant from the National Institute of...
IWGDF responds to key questions on management of diabetic foot patients...
In the face of increasing pressure on healthcare systems, caused by the COVID-19 pandemic, the International Working Group on the Diabetic Foot (IWGDF)—in collaboration...
US podiatrists outline triage system and community care focus to combat...
“Our goal is to reduce the burden on the healthcare system by keeping patients safe, functional, and at home during the COVID-19 pandemic,” state...
Recurrent ulcers “occur in anatomically-distinct locations” for patients in diabetic foot...
Diabetic foot ulcers frequently occur in different locations to previously-healed wounds for patients in diabetic foot remission, according to a secondary analysis of trial...
Exploring concepts in surgical offloading from current IWGDF guidelines
First revealed at the International Symposium on the Diabetic Foot (22–25 June 2019, The Hague, The Netherlands), new guidelines from the International Working Group...
Injectable adipose matrix improves healing rates for foot wounds in high...
The use of a new tissue allograft, which can be injected into areas of high pressure in the foot, has demonstrated clinical improvement in...
Topical oxygen therapy established as an effective healing method for DFUs...
Following their publication in the American Diabetes Association (ADA) journal Diabetes Care, results of a double-blinded, randomised controlled trial have been announced, showing that...
Orpyx launches sensory insoles with remote patient monitoring for diabetic foot...
Orpyx has announced the launch of its Orpyx SI Sensory Insoles with remote patient monitoring for the prevention of diabetic foot ulcers (DFU) and...
Launch of Neuropad for treatment of diabetic foot syndrome announced
Masters Speciality Pharma, a UK-headquartered pharmaceutical company "specialising in the global distribution of high-quality, life-changing medicines", has announced the launch of Neuropad, a rapid...
Sensory insole system for diabetic patients achieves reduction in recurrent ulcers
Improvements that enable better miniaturisation of technology leads to higher-quality wearable health solutions, including digital devices that were “never before possible’, said Breanne Everett...
EO2 oxygen delivery system demonstrates benefits for diabetic foot ulcer treatment
EO2 Concepts has announced the publication of a post hoc analysis from its randomised, double-blinded, multi-centre study, published last year in the Journal of Wound...
IWGDF unveils new infection and PAD guidelines for diabetic foot patients
Members of the International Working Group on the Diabetic Foot (IWGDF) presented up-to-date guidelines for the diagnosis, prognosis and treatment of diabetic foot ulcers...
IWGDF unveils new infection and PAD guidelines for diabetic foot patients
Members of the International Working Group on the Diabetic Foot (IWGDF) presented up-to-date guidelines for the diagnosis, prognosis and treatment of diabetic foot ulcers...
Podimetrics SmartMat demonstrates 97% sensitivity in predicting emergence of diabetic foot
Results published in Diabetes Care demonstrate that the Podimetrics SmartMat detected as many as 97% of developing nontraumatic plantar foot ulcers on average five weeks...
Delay designates disaster for diabetic foot ulcers
One might regard investigating delay in the treatment of ischaemic tissue lesions pointless and absurd at first thought because nobody wants to waste any time in...
Granulox treatment for chronic diabetic foot ulcers now available on prescription...
Infirst Healthcare’s haemoglobin spray, Granulox, has been added to the UK’s NHS Drug Tariff Part IX, establishing a new Haemoglobin category. Granulox—used for the...
